Register Now for NAAF's 39th Annual Patient Conference June 27-30, 2024 in Washington, D.C.!

Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents with Alopecia Areata (SADBE-HD)

Study type: Clinical Trials Posting date: 10/31/2022 Status: Recruiting Country: United States Eligibility:

Ages 12-17; diagnosed with alopecia areata; at least 10% scalp hair loss

Drug: Squaric Acid Dibutyl Ester Administration: Topical Sponsor: Investigator-initiated link: Click here Location: UT Health Houston


A clinical research study is currently looking for children ages 12-17 with a diagnosis of alopecia areata who have lost 10% or more of the hair on their head to participate in a study of a topical investigational drug.

During the course of this study, some people will receive the investigational product and some placebo (a substance that has no therapeutic effect) for the first 4 months. You will have a 2 in 3 chance of receiving the investigational product and a 1 in 3 chance of receiving a placebo. After the initial 4 months are completed, participants may receive the investigational product for an additional 8 months where there will be no placebo. The study will explore whether the investigational drug is safe and can help regrow hair. This study will last a period of up to 15 months and up to 16 visits.
Your participation in this study is at no cost to you.

You may qualify to participate if you:
• Are 12-17 years of age
• Have been diagnosed with alopecia areata
• Have at least 10% scalp hair loss

If you are interested in joining this clinical trial, please contact us at 713-500-8266 or 713-500-8278 and ask for the UTHealth Houston Dermatology Research Team.
We are located at 6500 West Loop South, Suite 200-A, Bellaire, TX 77401